Abstract
Background: Chemokines play a prominent role in inflammatory diseases. Results: Nanobodies targeting chemokines display high affinity and potently neutralize chemokine-induced receptor binding and signaling. Conclusion: Neutralizing Nanobodies targeting chemokines effectively inhibit chemokine function. Significance: Nanobodies directed against inflammatory and homeostatic chemokines form a promising new class of potent and specific inhibitors of chemokine function, to be used for research and therapeutic purposes. © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.
Original language | English |
---|---|
Pages (from-to) | 25173-25182 |
Journal | Journal of Biological Chemistry |
Volume | 2013 |
Issue number | 288 |
DOIs | |
Publication status | Published - 2013 |